Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease—friends or foes?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease—friends or foes?

Published:2014-04-03 Issue:10 Volume:28 Page:1941-1948
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Balan A,Lucchini G,Schmidt S,Schneider A,Tramsen L,Kuçi S,Meisel R,Bader P,Lehrnbecher T

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014127.pdf

Reference85 articles.

1. Krampera M . Mesenchymal stromal cell 'licensing': a multistep process. Leukemia 2011; 25: 1408–1414.

2. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315–317.

3. Carlo-Stella C, Di Nicola M, Gianni MA . [Mesenchymal stem cells: biology and clinical applications]. Tumori 2002; 88: A4–A7.

4. Aggarwal S, Pittenger MF . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815–1822.

5. Ramasamy R, Tong CK, Seow HF, Vidyadaran S, Dazzi F . The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 2008; 251: 131–136.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regenerative mesenchymal stem c ell‐derived extracellular vesicles: A potential alternative to c ell‐based therapy in viral infection and disease damage control;WIREs Mechanisms of Disease;2022-09-05

2. Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial;Journal of Hematology & Oncology;2022-03-07

3. Advances, Opportunities, and Challenges in Stem Cell-Based Therapy;Handbook of Stem Cell Therapy;2022

4. Advances, Opportunities, and Challenges in Stem Cell-Based Therapy;Handbook of Stem Cell Therapy;2022

5. Mesenchymal Stem Cell-Derived Exosomes and Their Potential Agents in Hematological Diseases;Oxidative Medicine and Cellular Longevity;2021-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3